Absence of detectable SARS-CoV-2 replication in ex vivo cultured cornea and cornea-derived epithelial cells

© 2022. The Author(s)..

PURPOSE: To study the possibility of SARS-CoV-2 to infect human corneal cells and tissues under standard corneal culture conditions using explants of COVID-19 donors and primary cornea-derived epithelial cells.

METHODS: Cornea isolated from deceased COVID-19 donors was cultured for 4 weeks, and SARS-CoV-2 replication was monitored by qRT-PCR. Furthermore, primary corneal epithelial cells from healthy donors were cultured ex vivo and infected with SARS-CoV-2 and human cytomegalovirus (HCMV) as a control. Infection status was assessed by western blotting and reporter gene expression using green fluorescent protein-expressing viral strains. ACE2 and TMPRSS2 receptor expression levels in cornea and epithelial cells were assessed by qRT-PCR.

RESULTS: We did not detect SARS-CoV-2 replication in 10 corneas isolated from deceased COVID-19 patients and cultured for 4 weeks, indicating absence of infection under natural conditions. Furthermore, high-titer SARS-CoV-2 infection of ex vivo cultured cornea-derived epithelial cells did not result in productive virus replication. In contrast, the same cells were highly permissive for HCMV. This phenotype could potentially be explained by low ACE2 and TMPRSS2 transcriptional activity in cornea and cornea-derived epithelial cells.

CONCLUSIONS: Our data suggest that cornea and limbal epithelial cells are refractory to productive SARS-CoV-2 infection. This could be due to the absence of robust receptor expression levels necessary for viral entry. This study adds further evidence to support the very low possibility of transmission of SARS-CoV-2 from an infected corneal transplant donor to a recipient in corneal organ cultures.

Medienart:

E-Artikel

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Zur Gesamtaufnahme - volume:261

Enthalten in:

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie - 261(2023), 2 vom: 16. Feb., Seite 435-446

Sprache:

Englisch

Beteiligte Personen:

Bayyoud, Tarek [VerfasserIn]
Vavouras Syrigos, Georgios [VerfasserIn]
Ruetalo Buschinger, Natalia [VerfasserIn]
Wude, Johanna [VerfasserIn]
Businger, Ramona [VerfasserIn]
Hu, Dan [VerfasserIn]
Iftner, Angelika [VerfasserIn]
Thaler, Sebastian [VerfasserIn]
Schindler, Michael [VerfasserIn]

Links:

Volltext

Themen:

ACE2 protein, human
Angiotensin-Converting Enzyme 2
COVID-19
Cornea organ transplantation
EC 3.4.17.23
EC 3.4.21.-
HCMV
Human cytomegalovirus
Journal Article
Ocular surface
SARS-CoV-2
TMPRSS2 protein, human

Anmerkungen:

Date Completed 23.01.2023

Date Revised 23.01.2023

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1007/s00417-022-05776-6

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM344404714